PCVX
Vaxcyte, Inc.
Vaxcyte, Inc. (PCVX) has 32 SEC Form 4 filings (82 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Aug 5, 2026.
The most active filer is CHIEF OPERATING OFFICER Wassil Jim with 6 filings. Insiders have net sold $7.6M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Grant E. Pickering
- Employees:507
- HQ:San Carlos, CA, US
- IPO:2020-06-12
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.6M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$8.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Dhaliwal Harpreet S.First filing | Chief Technical Ops Officer | Sale | 17,000 | $935K | Aug 5 | SEC ↗ |
| CHIEF OPERATING OFFICER | Sale | 2,250 | $121K | Aug 5 | SEC ↗ | |
| PRESIDENT AND CFO | Sale | 10,000 | $539K | Aug 5 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 18,198 | $1.0M | Jul 28 | SEC ↗ | |
| PRESIDENT AND CFO | Sale | 10,000 | $573K | Jul 6 | SEC ↗ | |
| CHIEF OPERATING OFFICER | Sale | 2,250 | $127K | Jul 6 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 24,237 | $1.3M | Jun 26 | SEC ↗ | |
PICKERING GRANTFirst filing | CHIEF EXECUTIVE OFFICER | Sale | 23,461 | $1.2M | Jun 19 | SEC ↗ |
GUGGENHIME ANDREWFirst filing | PRESIDENT AND CFO | Sale | 10,000 | $530K | Jun 19 | SEC ↗ |
| CHIEF OPERATING OFFICER | Sale | 2,250 | $111K | Jun 3 | SEC ↗ | |
| CHIEF OPERATING OFFICER | Sale | 2,250 | $128K | May 1 | SEC ↗ | |
| SVP, Finance & CAO | Sale | 3,000 | $180K | Apr 8 | SEC ↗ | |
| CHIEF OPERATING OFFICER | Sale | 2,250 | $131K | Apr 3 | SEC ↗ | |
| SVP, Finance & CAO | Sale | 1,892 | $105K | Mar 18 | SEC ↗ | |
Cowan ElviaFirst filing | SVP, Finance & CAO | Sale | 2,500 | $146K | Mar 11 | SEC ↗ |
Wassil JimFirst filing | CHIEF OPERATING OFFICER | Sale | 7,395 | $435K | Mar 11 | SEC ↗ |
Congress trading PCVX
See timeline →- DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-05-12
- DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-05-13
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
Vaxcyte, Inc. is in the Healthcare sector.